The purpose of email discussions is to share information about medicines and practice in NSW public hospitals. NSW TAG members are encouraged to respond to email discussion requests for information. However, it should be noted that information is only a current snapshot at the time the response is sent. The responses received are only representative of the hospitals participating in the discussion at the time (which may be small depending on the topic) and do not indicate a complete picture of current practices. It is recommended that email discussion topics are regularly brought to the attention of DTC meetings as they are likely to facilitate discussion of contemporary and emerging medicines and practice.
-
Open email discussions
Refer to NSW TAG email requests and TAG Mail for the latest Open Email discussion(s).
Email discussion responses are provided via email to NSW TAG
Completed email discussions webpage here.
Access to completed email discussions is only available to NSW TAG members. Please note, members should not share or pass on identifiable information to non-NSW TAG members. Non-NSW TAG members who are interested in an email discussion topic may obtain de-identified email discussions by contacting NSW TAG at nswtag@stvincents.com.au
A list of the recently completed email discussions is shown below.
-
Recently Completed Email Discussions
2024
- Infliximab dosing in Inflammatory Bowel Disease
- Handling of medicines by perfusionists
- DTC Assessment of non-GMO phage therapy
- DTC Pharmacist Positions in NSW
- Patient prioritisation for discharge medication list provision
- Protocol sharing of medical management of miscarriage
- Missing medicines from wards
- Medication reviews for inpatients in remote Multi-Purpose Services
Click here to access the email discussions running list of recent topics (last updated 14/04/2024).
Click here to access the completed email discussions page.
Page last updated 14 April 2024
